The role of diethylstilbestrol in the treatment of prostate cancer

Urology

Volumn 58, Issue 2 SUPPL. 1, 2001, Pages 108-113

  Malkowicz, S Bruce ^a,b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIETHYLSTILBESTROL; FLUTAMIDE; POLYESTRADIOL PHOSPHATE; PRASTERONE SULFATE; TESTOSTERONE; TRIPTORELIN; WARFARIN;

APOPTOSIS; CARDIOTOXICITY; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DRUG COST; DRUG EFFICACY; EDEMA; GYNECOMASTIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOT FLUSH; HUMAN; MALE; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; SURVIVAL TIME; TECHNIQUE; TESTOSTERONE RELEASE;

ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; CARDIOVASCULAR DISEASES; CLINICAL TRIALS; DIETHYLSTILBESTROL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ESTROGENS; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; ORCHIECTOMY; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 0034909874     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01252-3     Document Type: Conference Paper

References (27)

1. Studies on prostate cancer. 1. The effects of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate
2. A comparison of the effect of DES with low dose estramustine phosphate in the treatment of advanced prostate cancer; final analysis of a Phase III trial of EORTC
3. Estrogen dosage and suppression of testosterone levels in patients with prostatic carcinoma
4. Endocrine changes after diethylstilbestrol therapy; effects in prostatic neoplasm and pituitary-gonadal axis
5. Leuprolide versus diethylstilbestrol for metastatic prostate cancer
6. Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma; flutamide versus diethylstilbestrol
7. Phase III randomised study of zoladex versus stilboestrol in the treatment of advanced prostate cancer
8. The final analysis of the EORTC genito-urinary tract cancer co-operative group phase III clinical trial (protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate
9. Experience with low-dose oestrogen in the treatment of advanced prostate cancer; a personal view
10. Clotting predisposition in carcinoma of the prostate
11. Clotting predisposition in carcinoma of the prostate
12. The relationship between cardiovascular complications of estrogen therapy and fibrinolysis in patient with prostatic cancer
13. Thromboembolism during estrogen therapy of prostatic cancer; report on two cases
14. Effects of intravenous administration of high dose diethylstilbestrol diphosphate on serum hormonal levels in patients with hormone-refractory prostate cancer
15. Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells
16. A phase 1-2 trial of diethylstilbestrol plus low dose warfarin in advanced prostate carcinoma
17. A phase II trial of oral diethylstilbestrol as a second-line hormonal agent in advanced prostate cancer
18. Stilboestrol plus adrenal suppression as salvage treatment for patients failing treatment with luteinizing hormone-releasing hormone analogues and orchidectomy
19. Low-dose continuous oral fosfestrol is highly active in 'hormone-refractory' prostate cancer
20. Single-therapy androgen suppression in men with advanced prostate cancer; a systematic review and meta-analysis
21. Clinical and biological activity of an estrogenic herbal combination (PC-SPES) in prostate cancer
22. Prospective trial for the herbal supplement PC-SPES in patients with progressive prostate cancer